Tag Archives: Ivermectin

Breakthrough: Ivermectin Inhibits the SARS-CoV-2 Spike Protein From Binding to ACE2 Receptors in Human Tissue

Caveat: If you haven’t been jabbed! 

(Dr. Eddy Bittermann MD) Ivermectin, a common anti-parasite drug, has shown great efficacy in the fight against covid-19. For the first time, medical researchers have documented how ivermectin docks to the SARS-CoV-2 spike receptor-binding domain that is attached to the ACE2 receptor. In this way, ivermectin effectively inhibits viral attachment and replication, assisting a precise antiviral response that can target the SARS-CoV-2 spike protein at its most advantageous cleavage site. The researchers showed how ivermectin interferes with the attachment of the spike protein to the human cell membrane.

Continue reading